Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.668 USD | -0.30% | -14.77% | -26.79% |
Mar. 13 | Transcript : Gossamer Bio, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM | |
Mar. 12 | Gossamer Bio Announces Board of Directors Appointments | CI |
Business Summary
Number of employees: 135
Managers
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 | |
Richard Aranda
CTO | Chief Tech/Sci/R&D Officer | 64 | 18-01-31 |
Christian Waage
ADM | Chief Administrative Officer | 57 | 17-07-31 |
Bob Smith
PRN | Corporate Officer/Principal | - | Dec. 04 |
Jeff Boerneke
LAW | General Counsel | - | 20-12-31 |
Deanna Weber
HRO | Human Resources Officer | - | 18-03-31 |
Caryn Peterson
LAW | General Counsel | 65 | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 69 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | - | Mar. 10 |
John Quisel
BRD | Director/Board Member | 53 | Nov. 27 |
Russell Cox
BRD | Director/Board Member | 60 | 18-12-18 |
Sandra Milligan
BRD | Director/Board Member | - | 21-06-09 |
Renée Galá
BRD | Director/Board Member | 52 | 18-12-18 |
Steven Nathan
BRD | Director/Board Member | - | Mar. 10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 226,218,652 | 221,155,248 ( 97.76 %) | 0 | 97.76 % |
Company contact information
Gossamer Bio, Inc.
3013 Science Park Road Suite 200
92121, San Diego
+858 684 1300
http://www.gossamerbio.comGroup companies
Name | Category and Sector |
---|---|
Gossamer Bio Services, Inc.
Gossamer Bio Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Gossamer Bio, Inc., Gossamer Bio Services, Inc. operates as an American biopharmaceutical company which discovers, develops and commercializes immunology-based therapeutics. The private company is located in the US. |
Pharmaceuticals: Major
|
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.79% | 151M | |
+1.51% | 42.75B | |
+48.88% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GOSS Stock
- Company Gossamer Bio, Inc.